L
254.12
-3.93 (-1.52%)
| Previous Close | 258.05 |
| Open | 258.23 |
| Volume | 462,884 |
| Avg. Volume (3M) | 671,919 |
| Market Cap | 20,837,838,848 |
| Price / Earnings (TTM) | 22.53 |
| Price / Earnings (Forward) | 14.43 |
| Price / Sales | 1.54 |
| Price / Book | 2.45 |
| 52 Weeks Range | |
| Earnings Date | 23 Jul 2026 |
| TTM Dividend Yield | 1.17% |
| Profit Margin | 5.55% |
| Operating Margin (TTM) | 9.94% |
| Diluted EPS (TTM) | 8.68 |
| Quarterly Revenue Growth (YOY) | 5.30% |
| Quarterly Earnings Growth (YOY) | -6.70% |
| Total Debt/Equity (MRQ) | 79.13% |
| Current Ratio (MRQ) | 1.84 |
| Operating Cash Flow (TTM) | 1.63 B |
| Levered Free Cash Flow (TTM) | 967.92 M |
| Return on Assets (TTM) | 4.18% |
| Return on Equity (TTM) | 8.98% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Mixed | Bullish |
| Diagnostics & Research (Global) | Mixed | Bullish | |
| Stock | Labcorp Holdings Inc. | Bullish | Bullish |
AIStockmoo Score
2.3
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | 3.5 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -0.5 |
| Average | 2.25 |
|
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Mid Value |
| % Held by Insiders | 0.36% |
| % Held by Institutions | 96.44% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 330.00 (JP Morgan, 29.86%) | Buy |
| Median | 326.00 (28.29%) | |
| Low | 300.00 (Piper Sandler, 18.05%) | Hold |
| Average | 318.67 (25.40%) | |
| Total | 2 Buy, 1 Hold | |
| Avg. Price @ Call | 281.55 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Piper Sandler | 24 Feb 2026 | 300.00 (18.05%) | Hold | 287.13 |
| Baird | 18 Feb 2026 | 326.00 (28.29%) | Buy | 278.76 |
| JP Morgan | 18 Feb 2026 | 330.00 (29.86%) | Buy | 278.76 |
No data within this time range.
| TTM Dividend Yield | 1.17% |
| 4Y Average Dividend Yield | 0.97% |
| Payout Ratio | 33.22% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 27 Feb 2025 | 08 Jan 2025 | 12 Mar 2025 | 0.72 Cash |
| 26 Nov 2024 | 10 Oct 2024 | 13 Dec 2024 | 0.72 Cash |
| 29 Aug 2024 | 25 Jul 2024 | 13 Sep 2024 | 0.72 Cash |
| 24 May 2024 | 11 Apr 2024 | 12 Jun 2024 | 0.72 Cash |
| 26 Feb 2024 | 12 Jan 2024 | 13 Mar 2024 | 0.72 Cash |
| 07 Nov 2023 | 12 Oct 2023 | 12 Dec 2023 | 0.72 Cash |
| 07 Aug 2023 | 13 Jul 2023 | 08 Sep 2023 | 0.72 Cash |
| 17 May 2023 | 06 Apr 2023 | 08 Jun 2023 | 0.72 Cash |
| 22 Feb 2023 | 12 Jan 2023 | 13 Mar 2023 | 0.72 Cash |
| 16 Nov 2022 | 12 Oct 2022 | 09 Dec 2022 | 0.72 Cash |
| 17 Aug 2022 | 14 Jul 2022 | 09 Sep 2022 | 0.72 Cash |
| 18 May 2022 | 07 Apr 2022 | 09 Jun 2022 | 0.72 Cash |
| Show more | |||
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2025 | 0.720 | 1 | 0.29 |
| 2024 | 2.88 | 4 | 1.26 |
| 2023 | 2.88 | 4 | 1.27 |
| 2022 | 2.16 | 3 | 1.07 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |